Showing results (621-630 of 917) with videos related to
Sort By:
Pageof 92
JCI Insight|July 27, 2018
The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancerR Alex Harbison, Mark Kubik, Eric Q Konnick, et al.Pesticide Biochemistry and Physiology|December 29, 2025
Nationwide integrative analysis of pyrethroid resistance in Aedes aegypti from MexicoKevin A Ontiveros-Zapata, Alan E Juache-Villagrana, Selene M Gutierrez-Rodriguez, et al.Experimental and Therapeutic Medicine|December 25, 2023
Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitroGriselda A Cabral-Pacheco, Virginia Flores-Morales, Idalia Garza-Veloz, et al.Medicine International|April 10, 2023
Potassium permanganate use in the management of a wound induced by contact with Paederus: A case reportAgustin Lara-Esqueda, Yocelyn S Martinez-Gomez, Agustin D Lara-Basulto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell CarcinomaEduardo Méndez, Cristina P Rodriguez, Michael C Kao, et al.Tropical Medicine and Infectious Disease|July 25, 2025
First Report of the L925I kdr Mutation Associated with Pyrethroid Resistance in Genetically Distinct Triatoma dimidiata, Vector of Chagas Disease in MexicoMario C Saucedo-Montalvo, Jesus A Davila-Barboza, Selene M Gutierrez-Rodriguez, et al.NPJ Science of Food|October 14, 2023
Awakening the natural capability of psicose production in Escherichia coliJayce E Taylor, Dileep Sai Kumar Palur, Angela Zhang, et al.Journal of Community Genetics|October 27, 2021
"Right diet for the right person": a focus group study of nutritionist-dietitians' perspectives on nutritional genomics and gene-based nutrition adviceJacus S Nacis, Marilou R Galang, Jason Paolo H Labrador, et al.JAMA Health Forum|August 16, 2024
Safety Net Primary Care Capabilities After the COVID-19 PandemicKaren E Schifferdecker, Ching-Wen W Yang, Matthew B Mackwood, et al.Oral Oncology|December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion studyRenata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.Pageof 92